Pu X - Search Results

1

Treatment outcomes and prognosis of patients with primary and acquired BRAF-mutated non-small cell lung cancer: A multicenter retrospective study.

Wang W, Gu X, Si J, Pu X, Wang L, Chen H, Xu C, Zhang X, Yuan H, Lou G, Shao L, Zhang G, Song Z. Wang W, et al. Among authors: pu x. Genes Chromosomes Cancer. 2022 Sep;61(9):530-541. doi: 10.1002/gcc.23043. Epub 2022 Apr 23. Genes Chromosomes Cancer. 2022. PMID: 35396765

2

Immunotherapy for non-small cell lung cancers: biomarkers for predicting responses and strategies to overcome resistance.

Pu X, Wu L, Su D, Mao W, Fang B. Pu X, et al. BMC Cancer. 2018 Nov 8;18(1):1082. doi: 10.1186/s12885-018-4990-5. BMC Cancer. 2018. PMID: 30409126 Free PMC article. Review.

3

Prevalence and clinical significance of pathogenic germline BRCA1/2 mutations in Chinese non-small cell lung cancer patients.

Hu X, Yang D, Li Y, Li L, Wang Y, Chen P, Xu S, Pu X, Zhu W, Deng P, Ye J, Zhang H, Lizaso A, Liu H, Mao X, Huang H, Chu Q, Hu C. Hu X, et al. Among authors: pu x. Cancer Biol Med. 2019 Aug;16(3):556-564. doi: 10.20892/j.issn.2095-3941.2018.0506. Cancer Biol Med. 2019. PMID: 31565484 Free PMC article.

4

Association Between RET Fusions and Efficacy of Pemetrexed-based Chemotherapy for Patients With Advanced NSCLC in China: A Multicenter Retrospective Study.

Shen T, Pu X, Wang L, Yu Z, Li J, Zhang Y, Liang X, Chen H, Xu C, Song Z, Wang W. Shen T, et al. Among authors: pu x. Clin Lung Cancer. 2020 Sep;21(5):e349-e354. doi: 10.1016/j.cllc.2020.02.006. Epub 2020 Feb 10. Clin Lung Cancer. 2020. PMID: 32143967

5

Peripheral Blood Biomarkers Associated With Outcome in Non-small Cell Lung Cancer Patients Treated With Nivolumab and Durvalumab Monotherapy.

Jiang M, Peng W, Pu X, Chen B, Li J, Xu F, Liu L, Xu L, Xu Y, Cao J, Wang Q, Li K, Wang J, Wu L. Jiang M, et al. Among authors: pu x. Front Oncol. 2020 Jun 30;10:913. doi: 10.3389/fonc.2020.00913. eCollection 2020. Front Oncol. 2020. PMID: 32695663 Free PMC article.

6

Pemetrexed-based chemotherapy for non-small-cell lung cancer patients with EGFR exon 20 insertion mutation: a multicenter study.

Xu CW, Wang WX, Wang D, Wang QM, Pu XX, Zhu YC, Huang JH, Yu ZY, Cui ZL, Chen XH, Li JL, Fang Y, Wang H, Zhuang W, Lan SJ, Cai X, Zhang YB, Gao WB, Wang LP, She KL, Rao CZ, Zhou YF, Fang MY, Miao LY, Lei L, Lv TF, Song Y. Xu CW, et al. Among authors: pu xx. Transl Lung Cancer Res. 2020 Oct;9(5):1853-1861. doi: 10.21037/tlcr-20-382. Transl Lung Cancer Res. 2020. PMID: 33209607 Free PMC article.

7

Dacomitinib induces objective responses in metastatic brain lesions of patients with EGFR-mutant non-small-cell lung cancer: A brief report.

Peng W, Pu X, Jiang M, Wang J, Li J, Li K, Xu Y, Xu F, Chen B, Wang Q, Cao J, Chen Y, Wu L. Peng W, et al. Among authors: pu x. Lung Cancer. 2021 Feb;152:66-70. doi: 10.1016/j.lungcan.2020.12.008. Epub 2020 Dec 9. Lung Cancer. 2021. PMID: 33352385 Free article.

8

High-throughput sequencing detection and ensartinib treatment of lung cancer harboring NTRK1 fusion.

Song Z, Xu C, Pu X, Zhu Y, Wang W, Li X, Gao Y, Zhu W, He Y, Wu L, Mao L, Chen L, Chen M. Song Z, et al. Among authors: pu x. Cancer Commun (Lond). 2021 Feb;41(2):192-196. doi: 10.1002/cac2.12133. Epub 2021 Jan 16. Cancer Commun (Lond). 2021. PMID: 33452864 Free PMC article. No abstract available.

9

The prognostic impact of mild and severe immune-related adverse events in non-small cell lung cancer treated with immune checkpoint inhibitors: a multicenter retrospective study.

Wang W, Gu X, Wang L, Pu X, Feng H, Xu C, Lou G, Shao L, Xu Y, Wang Q, Wang S, Gao W, Zhang Y, Song Z. Wang W, et al. Among authors: pu x. Cancer Immunol Immunother. 2022 Jul;71(7):1693-1703. doi: 10.1007/s00262-021-03115-y. Epub 2021 Nov 24. Cancer Immunol Immunother. 2022. PMID: 34817639 Free PMC article.

10

Association between BRAF mutant classification and the efficacy of pemetrexed-based chemotherapy in Chinese advanced non-small cell lung cancer patients: a multicenter retrospective study.

Lei L, Wang WX, Zhu YC, Pu XX, Fang Y, Wang H, Zhuang W, Zhang YB, Wang LP, Xu CW, Fang MY. Lei L, et al. Transl Cancer Res. 2020 Oct;9(10):6039-6049. doi: 10.21037/tcr-20-480. Transl Cancer Res. 2020. PMID: 35117215 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,937 results

Search Page

Filters